Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Louis Desantis"'
Publikováno v:
Journal of prosthodontics : official journal of the American College of ProsthodontistsReferences. 30(S1)
Purpose The purpose of this Best Evidence Consensus Statement is to report on the prevalence, potential causes or association, treatment and cure of bruxism. Materials and methods A literature search limited to Clinical Trials, Randomized Controlled
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::443f1bafeddf20f55a4369c7180bc548
https://pubmed.ncbi.nlm.nih.gov/33331675
https://pubmed.ncbi.nlm.nih.gov/33331675
Autor:
Glyn Chidlow, John P. M. Wood, Neville N. Osborne, K.-G. Schmidt, Robert J Casson, Louis Desantis
Publikováno v:
Brain Research Bulletin. 62:525-528
Glaucoma is a chronic optic neuropathy in which retinal ganglion cells die over a number of years. The initiation of the disease and its progression may involve an ischaemic-like insult to the ganglion cell axons caused by an alteration in the qualit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cd94cb1e7e7acf9f0d6efe7131bf13d
https://doi.org/10.1016/s0361-9230(03)00070-4
https://doi.org/10.1016/s0361-9230(03)00070-4
Autor:
Mark R. Hellberg, Louis Desantis, Thomas R. Dean, N.A. Sharif, Paul W Zinke, Marsha A. McLaughlin, Verney L. Sallee
Publikováno v:
Journal of Ocular Pharmacology and Therapeutics. 17:421-432
Travoprost is the isopropyl ester prodrug of a high affinity, selective FP prostaglandin full receptor agonist. In contrast to travoprost acid's high affinity and efficacy at the FP receptor, there is only sub-micromolar affinity for the DP, EP1, EP3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea035c8e9b57502b186466c50aaa14e5
https://doi.org/10.1089/108076801753266802
https://doi.org/10.1089/108076801753266802
Publikováno v:
Experimental Eye Research. 72:79-86
It has previously been reported that the beta(1)-adrenoceptor antagonist, betaxolol, can protect retinal neurones from ischaemia when applied topically. It has further been shown that betaxolol can reduce influx of both sodium or calcium into neurone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75f1aa98b18afa22a4afcb2f160c9ef1
https://doi.org/10.1006/exer.2000.0929
https://doi.org/10.1006/exer.2000.0929
Publikováno v:
Ophthalmology Clinics of North America. 13:123-130
Currently, glaucoma therapy is directed at lowering intraocular pressure (IOP) primarily by pharmacologic means and to a lesser extent by surgery. 2,16,45 Although raised IOP can undoubtedly cause dysfunction to retinal ganglion cells and loss of vis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::969375d8a9ec863f5006f845c6632110
https://doi.org/10.1016/s0896-1549(05)70171-1
https://doi.org/10.1016/s0896-1549(05)70171-1
Autor:
Louis Desantis
Publikováno v:
Survey of Ophthalmology. 44:S119-S129
The development of topically active carbonic anhydrase inhibitors (CAIs) is a significant recent achievement in glaucoma medical treatment. Brinzolamide, the newest topical CAI, exhibits selectivity, high affinity, and potent inhibitory activity for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57fa05b2baa3e7cfa62cfe48cf7fba96
https://doi.org/10.1016/s0039-6257(99)00108-3
https://doi.org/10.1016/s0039-6257(99)00108-3
Publikováno v:
Survey of Ophthalmology. 43:S214-S222
This review addresses whether the antiglaucoma agents β-adrenergic antagonists and Ca 2+ entry blockers cause vasoactive effects in the retinal and other ocular vasculatures, as they do in other tissues. The potent vasodilating effects of Ca 2+ entr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa31c4de99bbb937bff97732e0cfc057
https://doi.org/10.1016/s0039-6257(99)00042-9
https://doi.org/10.1016/s0039-6257(99)00042-9
Publikováno v:
Experimental Eye Research. 67:73-81
This study tested the hypothesis that the beta-adrenergic antagonists betaxolol and timolol, cause retinal arteriolar vasodilatation in addition to their ability to reduce intraocular pressure (IOP), and compared their vasodilatory ability with that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c625fac6e3a41fcaba420cc60c0c6c19
https://doi.org/10.1006/exer.1998.0495
https://doi.org/10.1006/exer.1998.0495
Autor:
Verney L. Sallee, Pamela A. Gayheart, Nancy A. Longlet, Carl E. Jones, Melissa L. Hamrick, J. Stanley Bravenec, Louis Desantis
Publikováno v:
Drug Development Research. 28:161-168
Apraclonidine (p-aminoclonidine) a recognized α2-adrenergic agonist, has been approved for use with ocular laser surgery and is under consideration for use as a chronic treatment for glaucoma. The potential cardiovascular actions of apraclonidine in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0a38c6b7ee87cda223a3712179be9db
https://doi.org/10.1002/ddr.430280206
https://doi.org/10.1002/ddr.430280206
Autor:
James E. Chastain, Bette A McCue, Helga Wieland, R. Faulkner, Louis Desantis, Johan Przydryga, Jess T. Whitson, M. Curtis, Mark E. Sanders, D.C. Dahlin, G. Hollo
Publikováno v:
Investigative ophthalmologyvisual science. 47(1)
PURPOSE. To measure the concentration of betaxolol in tissues of humans with glaucoma and normal monkeys after topical administration. METHODS. Enucleated eyes (n 7) of patients with glaucoma (age range, 27–79 years), without apparent anatomic disr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8195d52873e203d167370da0ecfd004c
https://pubmed.ncbi.nlm.nih.gov/16384968
https://pubmed.ncbi.nlm.nih.gov/16384968